In case other shareholders on here aren’t aware, the EGM motion...

In case other shareholders on here aren’t aware, the EGM motion was lost and then the company subsequently tanked as a consequence with Mutton and Redford still in charge of the company.

And I was referring to the wastage of shareholders money and high income paid to Radford, not the specific issue of the clinical trial result.

I don’t care what the clinical trial result was.

I care about wastage of shareholders’ money by those in management.

In Bioxyne, there was wastage of shareholders money by the same persons of interest (ie Mutton and Radford).

And then Radford was involved in the Dickson Healthcare fiasco to boot.

Do THC shareholders really want history to repeat itself with these characters in charge of THC?

I would think not.

What was your point again?

It’s very much like the new Bioxyne situation as regards to allegations of wastage of shareholders money if you ask me.